Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» melanoma
melanoma
GSK melanoma drug combination wins accelerated U.S. approval
Yahoo/Reuters
Thu, 01/9/14 - 08:37 am
GSK
FDA
Tafinlar
Mekinist
melanoma
OncoSec Medical Poised for Exciting 2014
Wall St Cheat Sheet
Mon, 12/30/13 - 11:39 am
OncoSec Medical
melanoma
skin cancer
immunotherapy
The Race To Treat Stage III Melanoma Just Got A Lot More Interesting
Seeking Alpha
Wed, 12/18/13 - 08:18 am
melanoma
Amgen
Inovio
OncoSec Medical
TVEC
ZIOPHARM Reports Positive Interim Results in Patients With Advanced Melanoma From Ongoing Phase 1/2 Study of Ad-RTS-IL-12
Yahoo/Globe Newswire
Sat, 12/7/13 - 12:44 pm
Ziopharm
melanoma
Ad-RTS-IL-12
Pfizer And GlaxoSmithKline: Aiming For Melanoma Cure Supremacy
Seeking Alpha
Thu, 12/5/13 - 06:43 pm
Pfizer
GSK
melanoma
Bristol-Myers Squibb
AstraZeneca
Daiichi Sankyo
Novartis
Yervoy
palbociclib
Mekinist
Zelboraf
Merck Faces Off Against Bristol-Myers' Yervoy
Motley Fool
Mon, 12/2/13 - 05:00 pm
Yervoy
Bristol-Myers Squibb
MK-3475
melanoma
Pfizer, Glaxo to initiate study of combination therapy in patients with melanoma
The Fly on the Wall
Thu, 11/21/13 - 08:25 am
GSK
Pfizer
melanoma
trametinib
palbociclib
Amgen presents survival data from Phase 3 study of talimogene laherparepvec
Yahoo/Fly on the Wall
Mon, 11/18/13 - 04:39 pm
Amgen
Talimogene Laherparepvec
melanoma
Merck Scores in Investigational Melanoma Study Results
Yahoo/Wall St 24-7
Mon, 11/18/13 - 04:33 pm
Merck
melanoma
MK-3475
Merck: Why Oncology Smells Like Money
Seeking Alpha
Mon, 11/4/13 - 09:49 am
Merck
oncology
Roche
Bristol-Myers Squibb
MK-3475
melanoma
3 Cancer Investing Opportunities
Seeking Alpha
Tue, 10/1/13 - 10:10 am
Merck
cancer
AstraZeneca
Bristol-Myers Squibb
MK-1775
ovarian cancer
MK-3475
melanoma
Yervoy
Yervoy Battles Melanoma, but Can It Become a Blockbuster?
Motley Fool
Sun, 09/29/13 - 01:57 pm
Yervoy
melanoma
Bristol-Myers Squibb
Exelixis Announces Presentation of Updated Phase 1b Data for Cobimetinib (GDC-0973/XL518) in Combination with Vemurafenib at ECC 2013
Yahoo/BusinessWire
Sat, 09/28/13 - 11:58 am
metastatic melanoma
melanoma
Exelixis
Cobimetinib
Glaxo's Melanoma Drugs Gets FDA Priority Review
PharmaLive
Mon, 09/16/13 - 05:49 pm
melanoma
GSK
FDA
Tafinlar
Mekinist
trametinib
dabrafenib
metastatic melanoma
GSK’s MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Melanoma Misses First Co-Primary Endpoint
Yahoo
Thu, 09/5/13 - 08:15 am
GSK
melanoma
Agenus
With Vical Out, What's Next For The Melanoma Pipeline?
Seeking Alpha
Mon, 08/19/13 - 10:17 am
Vical
melanoma
Amgen
Celsion
OncoSec
Allovectin
ImmunoPulse
2 Biotechs Aim To Capitalize On The Treatment Of Melanoma
Seeking Alpha
Tue, 08/13/13 - 04:13 pm
melanoma
Amgen
OncoSec
Vical
TVEC
NeoPulse
Merck's Pipeline Of Drugs Should Make Up For Lost Sales To Generic Competition
Seeking Alpha
Mon, 08/12/13 - 09:11 am
Merck
generics
lambrolizumab
Odanacatib
melanoma
osteoporosis
non-small cell lung cancer
MannKind, Vical, GTx: Investors Predict Pivotal Clinical Trial Results
TheStreet.com
Mon, 08/5/13 - 07:23 am
MannKind
Vical
clinical trials
GTx
diabetes
Afrezza
melanoma
Allovectin-7
enobosarm
lung cancer-related muscle wasting
Merck jumps on melanoma treatment results
Marketwatch
Mon, 06/3/13 - 11:26 am
Merck
melanoma
lambrolizumab
ASCO
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »